Insider Transactions in Q4 2023 at Charles River Laboratories International, Inc. (CRL)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 14
2023
|
Victoria L Creamer EVP & Chief People Officer |
SELL
Open market or private sale
|
Direct |
5,526
-25.08%
|
$1,243,350
$225.0 P/Share
|
Dec 14
2023
|
Victoria L Creamer EVP & Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,526
+11.7%
|
$740,484
$134.4 P/Share
|
Nov 30
2023
|
Joseph W La Plume EVP, Corp Strategy & Develop |
SELL
Open market or private sale
|
Direct |
1,850
-7.41%
|
$364,450
$197.73 P/Share
|
Nov 20
2023
|
Birgit Girshick Corporate Executive VP & COO |
BUY
Open market or private purchase
|
Direct |
1,322
+2.89%
|
$247,214
$187.82 P/Share
|
Nov 14
2023
|
James C Foster Chairman, President and CEO |
BUY
Open market or private purchase
|
Direct |
5,620
+2.7%
|
$1,000,360
$178.05 P/Share
|
Nov 09
2023
|
Joseph W La Plume EVP, Corp Strategy & Develop |
SELL
Open market or private sale
|
Direct |
9,128
-14.17%
|
$1,579,144
$173.26 P/Share
|
Nov 09
2023
|
Joseph W La Plume EVP, Corp Strategy & Develop |
BUY
Exercise of conversion of derivative security
|
Direct |
9,128
+21.11%
|
$1,314,432
$144.67 P/Share
|